Tominaga M, Stewart J M
J Med Chem. 1975 Feb;18(2):130-3. doi: 10.1021/jm00236a003.
In a study of the relationship between structure and activity of bradykinin potentiating peptides (BPP), six analogs and homologs of peptides occurring in the venoms of Bothrops jararaca and Agkistrodon halys blomhoffii were synthesized and assayed in the isolated guinea pig ileum and rat uterus. None of the peptides had bradykinin-like activity and their bradykinin potentiating activity was much greater in the guinea pig ileum than in the uterus. The following observations were made with the guinea pig ileum. The introduction of Gln as the eigth residue in potentiator B (pGlu-Gly-Leu-Pro-Pro-Arg-Pro-Lys-Ile-Pro-Pro) and potentiator C (pGlu-Gly-Leu-Pro-Pro-Gly-Pro-Pro-Ile-Pro-Pro) produced a small increase in their bradykinin potentiating activity. Removal of the two N-terminal residues of [Gln8]-potentiator B and [Gln8]-potentiator C led to alterations in activity that paralleled those described earlier for the parent compounds (potentiators B and C). The peptide with the sequence pGlu-Trp-Pro-Ary-Pro-Lys-Trp-Ala-Pro was seven times as active as BPP5a, while the most potent natural BPP, a nonapeptide from B. jararaca venom, is reported to be only four times as active as BPP5a. An analog of the above-mentioned nonapeptide containing Pro8 instead of Ala8 was only as active as BPPa. For all of the peptides, as well as for potentiatrs B and C and BPP5a, the concentration vs. potentiating activity curves had similar shapes, with a plateau at twofold potentiation and a maximum potentiation of 10- to 11-fold. A direct action on the bradykinin receptors may be responsible for the effects observed at lower BPP concentration while the effects at higher concentrations may be due to kininase inhibition. The potentiating activities of potentiator B and its Gln8 analog persisted after the peptides were removed from the medium. This "sensitizing activity" was not observed with any of the other peptides.
在一项关于缓激肽增强肽(BPP)结构与活性关系的研究中,合成了六种来自巴西矛头蝮蛇和日本蝮蛇毒液中肽的类似物和同系物,并在离体豚鼠回肠和大鼠子宫中进行了测定。这些肽均无缓激肽样活性,且其缓激肽增强活性在豚鼠回肠中比在子宫中要强得多。在豚鼠回肠上有以下发现。在增强剂B(pGlu-Gly-Leu-Pro-Pro-Arg-Pro-Lys-Ile-Pro-Pro)和增强剂C(pGlu-Gly-Leu-Pro-Pro-Gly-Pro-Pro-Ile-Pro-Pro)中引入Gln作为第八个残基,使其缓激肽增强活性略有增加。去除[Gln8]-增强剂B和[Gln8]-增强剂C的两个N端残基导致活性改变,这与之前对母体化合物(增强剂B和C)描述的情况相似。序列为pGlu-Trp-Pro-Ary-Pro-Lys-Trp-Ala-Pro的肽的活性是BPP5a的七倍,而据报道,最有效的天然BPP(一种来自巴西矛头蝮蛇毒液的九肽)的活性仅为BPP5a的四倍。上述含Pro8而非Ala8的九肽类似物的活性仅与BPPa相当。对于所有这些肽,以及增强剂B和C以及BPP5a,浓度与增强活性曲线具有相似的形状,在两倍增强时有一个平台期,最大增强为10至11倍。在较低BPP浓度下观察到的效应可能是由于对缓激肽受体的直接作用,而在较高浓度下的效应可能是由于激肽酶抑制。从介质中去除肽后,增强剂B及其Gln8类似物的增强活性仍然存在。其他任何肽都未观察到这种“致敏活性”。